Related Experiment Video
Updated: Jun 1, 2026

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
Differences in the tumor DNA analysis of a hepatocellular-carcinoma and a synchronous fibrolamellar variant
1HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT SURG,DUCANE RD,LONDON W12 0NN,ENGLAND. ROYAL FREE HOSP,SCH MED,DEPT MED,LONDON NW3 2QG,ENGLAND. ROYAL FREE HOSP,SCH MED,DEPT SURG,LONDON NW3 2QG,ENGLAND. ROYAL FREE HOSP,SCH MED,DEPT HISTOPATHOL,LONDON NW3 2QG,ENGLAND.
Abstract:
A 60 year old man had two tumours resected from his liver which were shown histologically to be a well differentiated hepatocellular carcinoma and the fibrolamellar variant. Both are considered clinically distinct and of different pathogenesis and have not been previously reported occurring synchronously. DNA analysis revealed allele loss on chromosome 12 in the hepatocellular carcinoma which was not found in the fibrolamellar variant. This finding may suggest that hepatocellular carcinoma and fibrolamellar variant may have different molecular-genetic mechanisms for the development, in addition to their clinico-pathological difference.
